As a side note, as Ohm previously pointed out, if leronlimab works for the coronavirus, it will work for the flu. Treating a severe seasonal flu with a 2-3 week course of leronlimab at home will be a very beneficial and economical benefit to society rather than a hospitalization costing north of 10k. And in this case, bring a just reward to shareholders.